DAE HWA Pharmaceutical Co., Ltd. researches, develops, produces, and supplies pharmaceutical products in South Korea. The company offers skeletal muscle relaxants; gastro-intestinal drugs; corticosteroids; antihistamines; cardiovascular drugs; drugs for liver diseases; vitamins and tonics; antibiotics; injections; topical drugs; anti-inflammatory enzymes; analgesics and anti-inflammatory drugs, and antipyretics; plasters; and cough suppressants expectorants and mucolytics, as well as drugs affecting central nervous system and hemorrhoids disease. It also provides iron and calcium supply, and other products. In addition, the company offers transdermal drug delivery system, a pharmaceutical preparation that can be applied on the intact skin for systemic absorption, as well as active pharmaceutical ingredients. DAE HWA Pharmaceutical Co., Ltd. also exports its products to approximately 22 countries, including Asia, the European Union, America, and Africa. The company supplies its products to hospitals and pharmacies. DAE HWA Pharmaceutical Co., Ltd. was founded in 1984 and is headquartered in Seoul, South Korea.
daehwa pharm co ltd
(067080:Korea Exchange - KOSDAQ)
Phone: 82 2 6716 1071
Fax: 82 2 588 3422www.dhpharm.co.kr
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content.
|No competitor information is available for 067080.|
|View Industry Companies|
Sponsored Financial Commentaries
To contact DAEHWA PHARM CO LTD, please visit www.dhpharm.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.